The initiative "Arznei & Vernunft" is a joint project of the Hauptverband der österreichischen Sozialversicherungsträger, Pharmig, Österreichischer Ärztekammer and Österreichischer Apothekerkammer.
Information brochures made available for download inform patients about the clinical picture and the treatment options available. Among other things, the focus is on prevention and the need to change individual lifestyles in favour of one's own health.
Accessible under A&V
Drug information: Instructions for use, instructions for use, doping warning and much more.
This app gives you access to a comprehensive medicines database with more than 9,000 instructions for use. You can find your personal medication by scanning (barcode) or using the search function in the database.
With warnings and package inserts, the app provides you with a lot of important information.
Source: Austrian Chamber of Pharmacists
Pursuant to Section 31 (3) (12) ASVG, the Hauptverband der österreichischen Sozialversicherungsträger (Federation of Austrian Social Insurance Institutions) is obliged to issue aSocial Insurance Reimbursement Code for the supply of medicinal products for the account of a social insurance institution in the established sector. That list includes proprietary medicinal products authorised, reimbursable and secured in Austria.
Source: The Reimbursement Code online
An independent national network, to which all relevant institutions and experts of the Austrian health system belong, who deal with patient safety and quality assurance.
The primary goal is the networking of experts and the raising of awareness on topics related to patient safety and quality in health care.
Source: Patient Safety Platform
Patient attorneys are completely independent institutions of the different countries. They will help you to represent your rights as a patient in the health and hospital sectors.
Accessibility of the patient attorneys' offices
EPF is an umbrella organisation that works with patients' groups in public health and health advocacy across Europe. Our 74 members represent specific chronic disease groups at EU level or are national coalitions of patients. You can see a full list of our members here, with details should you need to contact them directly.
Patient training - the ABC of drug development
EUPATI - the European Patients' Academy on Therapeutic Innovation provides patients and the general public with scientifically sound, objective and understandable information on the research and development process of medicines.
It will strengthen the ability of patients and laypersons to advise regulatory authorities and ethics committees, for example in clinical trials.
In the EUPATI Austria Platform, representatives of patient organisations, science and industry work together to promote the further education of patients and their participation in the research and development (R&D) of drugs in Austria.
Our misson is to be the voice of allergy, asthma and COPD patients at European level and to be actively involved in the decisions impacting their health.
EURORDIS plays an important role in the orphan drug development process through participation in the Committee for Orphan Medicinal Products at the European Medicines Agency.